1 / 6

Autologous Cell Therapy Product Market Size - Industry Statistics, Share 2027

The global Autologous Cell Therapy Product market is forecasted to grow at a rate of 17.7% from USD 9.29 billion in 2019 to USD 35.64 billion in 2027. The major factors attributing to the growth of the autologous cell therapy business are the rising incidence of chronic conditions such as autoimmune diseases, cancer, a blood disorder, and others. A rise in the population suffering from incurable diseases is also creating a need for market growth.

industrytrends
Télécharger la présentation

Autologous Cell Therapy Product Market Size - Industry Statistics, Share 2027

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Autologous Cell Therapy Product Market to Reach USD 35.64 Billion By 2027

  2. Market Summary Market Size – USD 9.29 Billion in 2019, Market Growth - CAGR of 17.7%, Market Trends – Rise in cardiovascular incidences. The global Autologous Cell Therapy Product market is forecast to reach USD 35.64 Billion by 2027, according to a new report by Reports and Data. The primary factor driving the market is the growing incidence of chronic diseases such as cancer, autoimmune diseases, and blood cancer, among many others. The rise in the population suffering from chronic conditions is also augmenting the market growth. The global autologous cell therapy market is anticipated to showcase an intensely competitive atmosphere in the following years. • Further key findings from the report suggest • The global autologous cell therapy market increased at a significant CAGR over 2019 to 2027 due to the increasing predominance of cancer across the globe and raising funds from the government and market performers receiving support for the products. • Based on Application, the cancer segment accounted for more extensive market income share in 2019, owing to the rise in the number of patients suffering from this disease. Cancer has rapidly grown in the coming years. • According to the World Health Organization, there were 18.1 million new cases of cancer in 2018 and 9.6 million deaths in the same year. The cancer research UK has stated that the population suffering from cancer is expected to grow in the future. It is predicted that there will be 27.5 million new cases each year globally by the year 2040. • The Hospital emerged as the largest segment and is estimated to generate revenue of over USD 14.26 billion by 2027. The lucrative growth in the segment is due to the increase in the number of pipeline projects over the past few years. As per the Cancer Research Institute (CRI), the number of projects rose from 753 in 2018 to 1,011 in 2019.

  3. Market Summary Key Players: Brainstorm Cell Therapeutics Inc., Bayer AG, Daiichi Sankyo Co. Ltd., HolostemTerapieAvanzateSrl, FUJIFILM Holdings Corp., Teva Pharmaceutical Industries Ltd, Osiris Therapeutics Inc., Sumitomo Chemical Co. Ltd., Takeda Pharmaceutical Co. Ltd, and Vericel Corp among others. Segmentation: End-User Outlook (Revenue, USD Million; 2017-2027) Hospitals Ambulatory Centers Research Centers Others Application Outlook (Revenue, USD Billion; 2017-2027) Cancer Neurodegenerative Diseases Wound Healing Orthopedic Cardiovascular diseases Autoimmune Diseases Others Ask for Sample Report @ https://www.reportsanddata.com/sample-enquiry-form/3355

  4. Market Summary • Source Outlook (Revenue, USD Billion; 2017-2027) • Bone Marrow • Epidermis • Regional Outlook (Revenue, USD Billion; 2017-2027) • North America • U.S • Canada • Europe • Rest of Europe • Asia Pacific • South Korea • Rest of APAC • MEA • Saudi Arabia • UAE • Latin America • Brazil • Rest of LATAM Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/3355

  5. The report emphasizes the following key questions: Q.1.What are the most lucrative and promising growth prospects for the market? Q.2.Which sectors are expected to deliver a high growth rate and which industry aspects come into play in this advancement? Q.3.Which geographies are estimated to exhibit the highest growth and the underlying causes? Q.4.Which factors are impacting the future of the market and what are the driving factors? Q.5.What are the hurdles and challenges curtailing the industry’s growth in the forecast period?

  6. About US Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Contact US John Watson Head of Business Development Reports And Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com

More Related